XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Net sales $ 508,745 $ 469,961 $ 1,496,719 $ 1,448,884
Cost of goods sold 229,276 206,509 672,989 635,729
Gross profit 279,469 263,452 823,730 813,155
Selling, general and administrative expense 201,452 187,445 596,704 568,845
Research and Development Expense 49,924 43,336 150,681 137,085
Segment profit (loss) 28,093 32,671 76,345 107,225
Interest expense 5,634 5,822 16,846 15,658
Foreign exchange losses, net 1,210 2,166 3,576 8,910
Other (income) expense, net (1,439) (732) (13,824) (8,992)
Income before income taxes 22,688 25,415 69,747 91,649
Provision for income taxes (4,283) (8,045) (21,052) (28,038)
Net income including noncontrolling interests     48,695 63,611
Net income attributable to Bio-Rad $ 18,405 $ 17,370 $ 48,695 $ 63,611
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 0.63 $ 0.59 $ 1.66 $ 2.18
Weighted average common shares - basic 29,444 29,195 29,402 29,141
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 0.62 $ 0.59 $ 1.65 $ 2.17
Weighted average common shares - diluted 29,671 29,439 29,592 29,372